12 patents
Utility
Composition and method for treating neurological disease
5 Dec 23
The present disclosure is directed to methods of treating neurological disorders in a patient such as Parkinson's disease, drug-induced extrapyramidal reactions, and/or levodopa-induced dyskinesia comprising administering to the patient once daily in the morning a pharmaceutical composition comprising about 50 mg to about 400 mg of extended-release amantadine or a pharmaceutically acceptable salt thereof.
Glenn A. Meyer, Joaquina Faour, Ana Cristina Pastini, Marcelo Fernando Befumo
Filed: 22 Dec 20
Utility
Amantadine Compositions, Preparations Thereof, and Methods of Use
21 Apr 22
Provided herein are oral pharmaceutical compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and which have a low level of organic solvent.
Gregory T. WENT, Timothy J. FULTZ, Sangita GHOSH, Natalie MCCLURE
Filed: 4 Jun 21
Utility
Methods and Compositions for the Treatment of Seizure-related Disorders
3 Mar 22
Compositions and methods are provided for administering a pharmaceutical composition to a human patient.
Jack NGUYEN, David CHERNOFF, Sangita GHOSH, Gregory T. WENT, Timothy J. FULTZ
Filed: 11 Mar 21
Utility
Method of administering amantadine prior to a sleep period
14 Dec 21
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
Filed: 26 Dec 19
Utility
Methods of Administering Amantadine
19 Aug 21
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
Gregory T. WENT, Timothy J. FULTZ, Natalie MCCLURE
Filed: 3 Nov 20
Utility
Methods of using amantadine compositions
3 Aug 21
Provided herein are oral pharmaceutical compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and which have a low level of organic solvent.
Gregory T. Went, Timothy J. Fultz, Sangita Ghosh, Natalie McClure
Filed: 10 May 19
Utility
Amantadine compositions and preparations thereof
20 Jul 21
Provided herein are oral pharmaceutical compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and which have a low level of organic solvent.
Gregory T. Went, Timothy J. Fultz, Sangita Ghosh, Natalie McClure
Filed: 7 Nov 19
Utility
Methods and compositions for the treatment of seizure-related disorders
27 Apr 21
Compositions and methods are provided for administering a pharmaceutical composition to a human patient.
Jack Nguyen, David Chernoff, Sangita Ghosh, Gregory T. Went, Timothy J. Fultz
Filed: 5 Jan 18
Utility
Methods and compositions for the treatment of seizure-related disorders
13 Apr 21
Compositions and methods are provided for administering a pharmaceutical composition to a human patient.
Jack Nguyen, David Chernoff, Sangita Ghosh, Gregory T. Went, Timothy J. Fultz
Filed: 30 Dec 16
Utility
Amantadine Compositions and Methods of Use
29 Jul 20
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
Filed: 25 Dec 19
Utility
Methods of administering amantadine
11 May 20
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
Gregory T. Went, Timothy J. Fultz, Natalie McClure
Filed: 12 Nov 18
Utility
Amantadine Compositions, Preparations Thereof, and Methods of Use
4 Mar 20
Provided herein are oral pharmaceutical compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and which have a low level of organic solvent.
Gregory T. WENT, Timothy J. FULTZ, Sangita GHOSH, Natalie MCCLURE
Filed: 6 Nov 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first